Edition:
United States

Immuron Ltd (IMC.AX)

IMC.AX on Australia Stock Exchange

0.29AUD
22 Feb 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.29
Open
$0.29
Day's High
$0.29
Day's Low
$0.29
Volume
40,234
Avg. Vol
63,832
52-wk High
$0.42
52-wk Low
$0.22

IMC.AX

Chart for IMC.AX

About

Immuron Limited is a biopharmaceutical company. The Company focuses on the research and development of bovine-colostrum enriched with antibodies of choice for the treatment and prevention of a range of infections and immune modulated diseases. The Company has three segments: Research and Development (R&D), HyperImmune Products... (more)
No analyst recommendations are available for IMC.AX.

Overall

Beta: -0.93
Market Cap(Mil.): $30.64
Shares Outstanding(Mil.): 105.64
Dividend: --
Yield (%): --

Financials

  IMC.AX Industry Sector
P/E (TTM): -- 28.81 29.68
EPS (TTM): -0.05 -- --
ROI: -96.67 13.56 13.06
ROE: -96.67 14.44 14.19

BRIEF-Immuron receives $1.6m research and development tax concession refund

* Immuron receives $1.6m research and development tax concession refund Source text for Eikon: Further company coverage:

Nov 28 2016

More From Around the Web

Earnings vs. Estimates